Antiretroviral chemoprophylaxis in children and adolescents victims of rape in Abidjan.
OBJECTIVE
We described the use of antiretroviral drugs to prevent HIV transmission among children and adolescents victims of rape in Abidjan (Ivory Coast).


METHODS
We conducted a retrospective and descriptive study on children (0-9 years) and adolescents (10-19 years) victims of rape between 2000 and 2013. We analyzed the patients' socio-demographic characteristics and the modality of the chemoprophylaxis.


RESULTS
We included 10 children and 89 adolescents in the study. The median age was 16 years old (3-19 years). The median time to consultation was 23.5 hours (5-152 hours). The antiretroviral chemoprophylaxis was administered to 92 patients (93%). No HIV and HBV seroconversion was observed after a 3-month follow-up.


CONCLUSIONS
A better management of rape victims is required in Abidjan.
Service des maladies infectieuses et tropicales, CHU de Treichville, 01 BP V 3, Abidjan 01, Côte d'Ivoire. Electronic address: docehui@yahoo.fr.
E
E
Ehui
Service de pédiatrie, CHU de Treichville, 01 BP V 3, Abidjan 01, Côte d'Ivoire.
L S
LS
Couitchéré
Service des maladies infectieuses et tropicales, CHU de Treichville, 01 BP V 3, Abidjan 01, Côte d'Ivoire.
G A
GA
Kouakou
Service des maladies infectieuses et tropicales, CHU de Treichville, 01 BP V 3, Abidjan 01, Côte d'Ivoire.
A
A
Doumbia
Service des maladies infectieuses et tropicales, CHU de Treichville, 01 BP V 3, Abidjan 01, Côte d'Ivoire.
A N
AN
Kassi
Service des maladies infectieuses et tropicales, CHU de Treichville, 01 BP V 3, Abidjan 01, Côte d'Ivoire.
C M
CM
Mossou
Service de gynéco-obstétrique, CHU de Treichville, 01 BP V 3, Abidjan 01, Côte d'Ivoire.
P Y
PY
Guié
Service des maladies infectieuses et tropicales, CHU de Treichville, 01 BP V 3, Abidjan 01, Côte d'Ivoire.
S
S
Eholié
D000293:Adolescent; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D007560:Cote d'Ivoire; D005260:Female; D005500:Follow-Up Studies; D015483:HIV Antibodies / Q000097:blood; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D006679:HIV Seropositivity; D006301:Health Services Needs and Demand; D006509:Hepatitis B / Q000635:transmission; D006510:Hepatitis B Antibodies / Q000097:blood; D006801:Humans; D008297:Male; D011902:Rape; D012189:Retrospective Studies; D000069078:Seroconversion; D012959:Socioeconomic Factors; D055815:Young Adult
D019380:Anti-HIV Agents; D015483:HIV Antibodies; D006510:Hepatitis B Antibodies
Chemoprophylaxis; Chimioprophylaxie; HIV; Rape; VIH; Viol